Hospira Inc.: KETOROLAC Tromethamine Inj., USP, 30 mg (30 mg/mL), 1 mL Fill,
Recall reason: Crystallization; identified as calcium salt of Ketorolac. Recalled by Hospira Inc.. Distribution: Nationwide, Puerto Rico, Guam, Canada and Singapore. Classification (Class II — potential health risk). Affected lots/NDC/dates: 31077DK, 31078DK, 31338DK, 31339DK, 31340DK, EXP 01JUL2015; 32068DK, 32069DK, EXP 01AUG2915; 33270DK, EXP 01SEP2015; 340. Return the recalled medication to the pharmacy where you purchased it for a full refund of the purchase price.
📬 Get email alerts for new Product Recalls & Refunds
Free — we'll email you when new matching opportunities appear. No spam, unsubscribe anytime.
New here? Here's how Reward Opportunity works:
🔔 More Product Recalls & Refunds
Product recalls offering refunds, replacements, or repairs to consumers who purchased the item.
Browse all product recalls & refunds →Not just this one — find everything you qualify for
Our AI scans 8,000+ bounties, settlements, grants, recalls, and paid studies against your profile to rank what you can actually claim.
Get My Free Match Report